The Bell Perspective

UBC's strategic buyout of AI-specialist Evidinno signals a major shift in evidence generation, promising faster, smarter data solutions for biopharma.

With its rare disease drug JURVIGO® in late-stage trials, Mezzion appoints a veteran leader to navigate the path to approval and commercialization.

At CES 2026, accessory giant JSAUX unveils its new Nintendo Switch 2 lineup and a strategic roadmap for Valve's future hardware ecosystem.

Iron Software funds biochar kilns in Chiang Mai, tackling an environmental crisis that threatens the city's 'mini Silicon Valley' status.

Marking 15 years, ABCmouse relaunches with a stunning redesign and a new free tier, aiming to broaden access to its proven early education platform.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

A new integration brings Ceres AI's insights directly into the John Deere Operations Center, tackling data fragmentation for growers and insurers alike.

Kodiak AI partners with automotive giant Bosch to scale autonomous truck hardware, a landmark deal set to accelerate the driverless freight revolution.

Essential home-care staff will rally against a full return-to-office mandate, citing shrunken office space and potential disruptions to patient care.

The Emberly at Heritage Glen opens, combining advanced AI care monitoring with a people-first philosophy to meet Fort Worth’s growing senior care needs.

After resolving a cease trade order, A.I.S. Resources is set to resume trading, putting its diverse gold and lithium projects back in the market spotlight.

A landmark certification brings enterprise-level reliability to residential batteries. But is this a new era for energy security or expensive overkill?

A new partnership aims to boost low colorectal cancer screening rates by combining trusted patient education with the promise of simpler blood-based tests.

Chip Wilson nominates three directors in a bid to remake Lululemon's board, criticizing its leadership and demanding a return to product innovation.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

In a strategic all-equity deal, JAPEX subsidiary Peoria Resources acquires 101,000 acres in Colorado, signaling a major pivot for the Japanese energy giant.

The custom apparel leader partners with a top agency to expand its reach into sports, entertainment, and universities. Here's what the deal means for fans.

A Phase 1 trial for Moleculin's WP1066 shows encouraging safety and anti-tumor activity for children with deadly brain tumors like DIPG.

The City of Fresno deploys seven grid-independent, solar-powered EV chargers, boosting energy resilience and accelerating its fleet's green transition.